Descriptor English: | Dipyridamole | ||||
Descriptor Spanish: |
Dipiridamol
| ||||
Descriptor Portuguese: | Dipiridamol | ||||
Descriptor French: | Dipyridamole | ||||
Entry term(s): |
Antistenocardin Apo Dipyridamole Apo-Dipyridamole Cerebrovase Cléridium Curantil Curantyl Dipyramidole Kurantil Miosen Novo Dipiradol Novo-Dipiradol Persantin Persantine |
||||
Tree number(s): |
D03.383.742.175 |
||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D004176 | ||||
Scope note: | A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752) |
||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||
Pharm Action: |
Phosphodiesterase Inhibitors Inhibidores de Fosfodiesterasa Inibidores de Fosfodiesterase Inhibiteurs de la phosphodiestérase inhibidores de fosfodiesterasas Platelet Aggregation Inhibitors Inhibidores de Agregación Plaquetaria Antiagrégants plaquettaires inhibidores de la agregación plaquetaria Inibidores da Agregação Plaquetária Vasodilator Agents Vasodilatadores Vasodilatadores Vasodilatateurs vasodilatadores |
||||
Registry Number: | 64ALC7F90C | ||||
CAS Type 1 Name: | Ethanol, 2,2',2'',2'''-((4,8-di-1-piperidinylpyrimido(5,4-d)pyrimidine-2,6-diyl)dinitrilo)tetrakis- | ||||
Public MeSH Note: | 66; was PERSANTIN 1963-65 |
||||
History Note: | 66; was PERSANTIN 1963-65 |
||||
DeCS ID: | 4235 | ||||
Unique ID: | D004176 | ||||
NLM Classification: | QV 150 | ||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||
Date Established: | 1966/01/01 | ||||
Date of Entry: | 1999/01/01 | ||||
Revision Date: | 2017/05/24 |
-
-
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds
|
Dipyridamole
- Preferred
Apo-Dipyridamole
- Narrower
Cerebrovase
- Narrower
Persantine
- Narrower
Curantil
- Narrower
Miosen
- Narrower
Novo-Dipiradol
- Narrower
Antistenocardin
- Narrower
Cléridium
- Narrower
Concept UI |
M0006533 |
Scope note | A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752) |
Preferred term | Dipyridamole |
Entry term(s) |
Dipyramidole |
Concept UI |
M0485237 |
Preferred term | Apo-Dipyridamole |
Entry term(s) |
Apo Dipyridamole |
Concept UI |
M0485238 |
Preferred term | Cerebrovase |
Concept UI |
M0006534 |
Preferred term | Persantine |
Entry term(s) |
Persantin |
Concept UI |
M0374377 |
Preferred term | Curantil |
Entry term(s) |
Curantyl Kurantil |
Concept UI |
M0485235 |
Preferred term | Miosen |
Concept UI |
M0485234 |
Preferred term | Novo-Dipiradol |
Entry term(s) |
Novo Dipiradol |
Concept UI |
M0374378 |
Preferred term | Antistenocardin |
Concept UI |
M0485236 |
Preferred term | Cléridium |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey